ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MOL Moleculin Biotech Inc

0.00
0.00 (0.00%)
- - Realtime Data
Share Name Share Symbol Market Type
Moleculin Biotech Inc TG:MOL Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

MOL Sees Average Oil Price Around $110 A Barrel in 2013-2014 -CEO

26/02/2013 1:18pm

Dow Jones News


Moleculin Biotech (TG:MOL)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Moleculin Biotech Charts.

By Veronika Gulyas

BUDAPEST--Hungarian oil and gas company MOL Nyrt. (MOL.BU) expects oil prices to remain in a range about $110 a barrel in 2013-2014, oscillating around the 2012 level, the firm's chief executive said Tuesday at a press briefing.

MOL published its fourth-quarter and full 2012 results late Monday and its drilling update earlier Tuesday.

Foreseeing a difficult operating environment this year, the CEO Jozsef Molnar expects a slight deterioration in gasoline and diesel crack spreads in 2013 from the 2012 average levels when they were $190 a metric ton and $130 a ton respectively.

The company forecasts a "significant" rise in what is dubbed the Robin Hood tax, a state levy on energy firms in Hungary on top of the sector-wide "crisis" taxes and corporate taxes.

The company paid almost 10 billion forints ($45 million) in Robin Hood tax in 2012, while the 2013 level will depend on the consolidated, audited full-year 2012 profit, Janos Simola, MOL's deputy CEO responsible for finances, said.

To offset higher taxes, the utility is due to continue its downstream streamlining program, where it sees a combined savings and revenue-increasing plan bringing in $400 million in 2013, as part of the 2012-2014 program that aims to save MOL $500 million-$550 million.

Besides savings within the downstream segment--which also includes filling stations--the firm expects growth in Romania, Serbia, Slovenia and the Czech Republic; consolidation in Bosnia-Herzegovina and Croatia; and keeping its market leading position in Hungary and Slovakia.

Write to Veronika Gulyas at veronika.gulyas@dowjones.com

1 Year Moleculin Biotech Chart

1 Year Moleculin Biotech Chart

1 Month Moleculin Biotech Chart

1 Month Moleculin Biotech Chart

Your Recent History

Delayed Upgrade Clock